| Name | Title | Contact Details |
|---|---|---|
Darrell Riekena |
Chief Operating Officer | Profile |
Leading-edge designer and manufacturer of cannabis confectionery in Canada
Kitchen United is introducing a new and unique commercial kitchen for rent opportunity for food service providers to realize their fullest business potential.
Headquartered in Le Mars, Iowa, Wells is the largest family-owned privately held ice cream processor in the United States, producing more than 900 ice cream and frozen novelties treats. Wells produces Blue Bunny® ice cream, frozen novelties and specialty frozen desserts along with the iconic Bomb Pop® brand. So much ice cream is produced in Le Mars by Wells that the city was designated as the Ice Cream Capital of the World® by the Iowa legislature! Blue Bunny branded items are distributed across the nation. Ice cream enthusiasts can find their favorite Blue Bunny products in grocery, convenience and club stores, on mobile vending trucks and in foodservice settings (such as educational institutions, hospitals and restaurants). The company’s corporate office and two ice cream plants are located in Le Mars. Over 2,500 production, sales, office, and support personnel make up the Wells family. With its state-of-the-art production facilities the company is cited by many industry experts as one of the most technically advanced in the industry.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.